Missed opportunities in the diagnosis of heart failure: a real‐world assessment

Author:

Ferreira João Pedro123ORCID,Taveira‐Gomes Tiago456,Canelas‐Pais Mariana45,Phan Phillip7,Bernardo Filipa8,Andersson Sundell Karolina9,Almeida Mário8,Martinho Hugo8,Gavina Cristina12310

Affiliation:

1. Department of Physiology and Cardiothoracic Surgery, Cardiovascular R&D Centre ‐ UnIC@RISE Faculty of Medicine of the University of Porto Porto Portugal

2. Department of Internal Medicine, Heart Failure Clinic Centro Hospitalar de Vila Nova de Gaia/Espinho Vila Nova de Gaia Portugal

3. Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F‐CRIN INI‐CRCT Nancy France

4. Department of Community Medicine, Information and Decision in Health Faculty of Medicine of the University of Porto Porto Portugal

5. MTG Research and Development Lab Porto Portugal

6. Faculty of Health Sciences University Fernando Pessoa Porto Portugal

7. AstraZeneca Cambridge UK

8. AstraZeneca Lisbon Portugal

9. AstraZeneca Gothenburg Sweden

10. Department of Cardiology Pedro Hispano Hospital Matosinhos Portugal

Abstract

AbstractAimsHeart failure (HF) is a leading cause of hospitalization worldwide. An early HF diagnosis is key to reducing hospitalizations. We used electronic health records (EHRs) to characterize HF pathways at the primary care physician (PCP) level prior to a first HF hospitalization (hHF). This study aimed to identify missed opportunities for HF diagnosis and management at the PCP level before a first hHF.Methods and resultsThis cohort study used EHRs of a large health care organization in Portugal. Patients with incident hHF between 2017 and 2020 were identified. Missed opportunities were defined by the absence of any of the following work‐up in the 6 months after signs or symptoms had been recorded: lab results and electrocardiogram, natriuretic peptides, echocardiogram, referral to HF specialist, or HF medication initiation. A total of 2436 patients with a first hHF were identified. The median (interquartile range) age at the time of hospitalization was 81 (14) years, and 1361 (56%) were women. Most patients were treated with cardiovascular drugs prior or at index event. A total of 720 (30%) patients had records of HF signs or symptoms, 94% (n = 674) within 6 months prior to hHF. Among patients with recorded HF signs or symptoms, 410 (57%) had clinical management considered adequate before signs and symptoms were recorded. Of the 310 remaining patients, 155 (50%) had a follow‐up that was considered inadequate.ConclusionsRelatively few patients with a first hHF had primary care records of signs or symptoms prior to admission. Of these, nearly half had inadequate management considering diagnosis and treatment. These data suggest the need to improve PCP HF awareness.

Funder

AstraZeneca

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3